Dr. Stephen Henry Wrzesinski, MD, PhD
- Medicare services, 2024
- 34,684
- Medicare patients, 2024
- 411
- Part D claims, 2024
- 783
- Publications
- 9
- Clinical trials
- 2
- Practice address
- 400 Patroon Creek Blvd, Albany, NY 12206
- Practice phone
- Call (518) 239-5200
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Akira Medical Imaging + Wellness
Mammography / Breast Imaging Center · Albany, New York
Find Dr. Wrzesinski's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Stephen Henry Wrzesinski is a medical oncologist in Albany, New York
Dr. Wrzesinski practices at Akira Medical Imaging + Wellness in Albany, New York.
Dr. Wrzesinski's NPI, 1780856971, was assigned on March 27, 2008. Dr. Wrzesinski graduated from State University of NY Upstate Medical University in 2002. Dr. Wrzesinski holds New York license 260820.
- NPI
- 1780856971NPI Registry (opens in a new tab)
- Medicare PAC ID
- 7113105958
- NPI enumeration date
- March 27, 2008
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (518) 239-5200
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
- Estimated age
- 50
- Medical school graduation
- 2002
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Stephen Henry Wrzesinski practices at Akira Medical Imaging + Wellness in Albany, New York
Dr. Wrzesinski's primary practice is Akira Medical Imaging + Wellness, at 400 Patroon Creek Blvd, Albany, NY 12206. The practice phone is (518) 239-5200.
- Akira Medical Imaging + Wellness400 Patroon Creek Blvd, Albany, NY 12206Phone(518) 239-5200
Source: Dmand AI Affiliation Data
Dr. Stephen Henry Wrzesinski is affiliated with 7 sites of care and 2 medical groups
Dr. Wrzesinski's primary practice is Akira Medical Imaging + Wellness in Albany, New York. Dr. Wrzesinski is also affiliated with Albany Medical Center. The medical group on file is Samaritan Hospital. Dmand AI also links Dr. Wrzesinski to 4 more hospitals, 1 hospice and 1 medical group, each named with a free account. Dr. Wrzesinski's employer is on file too: a breast imaging center.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Stephen Henry Wrzesinski's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Wrzesinski practices, 7 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Akira Medical Imaging + Wellness | Available with a free account |
| +6 more sites and 1 medical group | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Stephen Henry Wrzesinski is one of 458 medical oncologists in New York
Medical oncology is Dr. Wrzesinski's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Wrzesinski is licensed in New York.
Specialties and state licenses
- Medical oncology, New YorkPrimary
Medical oncologists near Dr. Wrzesinski
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Stephen Henry Wrzesinski billed Medicare for 34,684 services in 2024
CMS data shows 34,684 Medicare services from Dr. Wrzesinski across 54 procedure codes in 2024, for 411 Medicare patients. Medicare paid $940,668 for them.
Dr. Wrzesinski's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Drugs given in the office
- 2023: 41,4302024: 26,43936%
- Other services
- 2023: 2,5402024: 3,47237%
- Lab and pathology
- 2023: 2,1192024: 2,38813%
- Tests and treatments
- 2023: 8562024: 8944%
- Office and hospital visits
- 2023: 7772024: 7612%
- Surgery
- 2023: 6002024: 6315%
- Imaging
- 2023: 812024: 9922%
Where Dr. Wrzesinski's Medicare services took place, 2024
- In an office34,615100%
- In a facility690%
Dr. Wrzesinski compared with the New York median for medical oncologists, 2024
- Dr. Wrzesinski
- New York median
- Medicare services
- 34,684vs 340102.0 times
- Medicare patients
- 411vs 1123.7 times
- Part D claims
- 509vs 1303.9 times
Medians across 421 medical oncologists in New York with Dmand AI profiles that report each measure.
Dr. Wrzesinski's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Wrzesinski?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Wrzesinski and other medical oncologists in New York.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Stephen Henry Wrzesinski treated 411 Medicare patients in 2024, average age 74
CMS counts 411 Medicare patients who saw Dr. Wrzesinski in 2024. The largest group is 65 to 74, with 175 patients. 73% of them have high blood pressure, and 71% have high cholesterol. 13% are also on Medicaid. Their average risk score is 2.36, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.
Across all payers, Dmand AI patient panel data puts Dr. Wrzesinski's median patient age at 70, with 47% women.
Dr. Wrzesinski's Medicare patients by age, 2024
Dr. Wrzesinski's Medicare patients by sex, 2024
- Women19848%
- Men21352%
Chronic conditions among Dr. Wrzesinski's Medicare patients, 2024
- High blood pressure73%
- High cholesterol71%
- Cancer66%
- Arthritis37%
- Anxiety33%
- Ischemic heart disease32%
- Diabetes27%
- Mood disorders25%
Share of Medicare patients with each condition. A patient can have several.
Dr. Wrzesinski's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 70
Patient panel by sex, all payers
- Women47%
- Men52%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Stephen Henry Wrzesinski wrote 783 Medicare Part D claims in 2024
In 2024, Dr. Wrzesinski wrote 783 Medicare Part D claims for 108 patients. 76% of them were for generic drugs. CMS names the drug for 509 of them, across 21 drugs with 11 or more claims each, at $909,269 in total drug cost. In 2023, CMS named 632 claims across 24 drugs.
Dr. Wrzesinski's Part D claims by kind of drug, 2024
- Generic595 claims76%
- Brand-name188 claims24%
Dr. Wrzesinski's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Wrzesinski's Part D claims, 2024
- Opioids4%28 of 783 claims
- Antibiotics3%20 of 783 claims
- Antipsychotics, patients 65 and over2%15 of 783 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 6322024: 50919%
Drugs named by CMS: 21 in 2024, 24 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Stephen Henry Wrzesinski offers telehealth to Medicare patients
Dr. Wrzesinski accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Wrzesinski as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Stephen Henry Wrzesinski has 9 publications on record
Dmand AI links 9 papers to Dr. Wrzesinski, published from 2010 to 2022. 2010 was the busiest year, with 2. The most frequent topics are Antineoplastic Agents. Dr. Wrzesinski's most frequent co-authors are Atu Agawu, MD, MPH, Zainub Ajmal, MD and Marc Stuart Ernstoff, MD.
Dr. Wrzesinski's papers by year, 2010 to 2022
Topics Dr. Wrzesinski writes about most
- Antineoplastic Agents
Dr. Wrzesinski's most frequent co-authors
- Atu Agawu, MD, MPH1 shared paper
- Zainub Ajmal, MD1 shared paper
- Marc Stuart Ernstoff, MD1 shared paper
Recent publications by Dr. Wrzesinski
J Oncol Pharm Pract
Mouse mammary tumor virus in anti-mitochondrial antibody producing mouse models (opens in a new tab)
J Hepatol
See who Dr. Wrzesinski researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Wrzesinski works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Stephen Henry Wrzesinski has worked on 2 clinical trials
Dmand AI links Dr. Wrzesinski to 2 clinical trials, 2 of them phase 2 studies. 1 is still active or recruiting. Conditions studied include Melanoma, Squamous Cell Carcinoma of Head and Neck and Carcinoma, Squamous Cell.
Conditions in Dr. Wrzesinski's trials
- Melanoma
- Squamous Cell Carcinoma of Head and Neck
- Carcinoma, Squamous Cell
- Nevi and Melanomas
Investigators on the most trials with Dr. Wrzesinski
- Jeffrey T. Yorio, MD2 shared trials
- Kartik Anand, MD1 shared trial
- Subramanyeswara Rao Arekapudi, MD, MPH1 shared trial
Recent clinical trials with Dr. Wrzesinski
Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Stephen Henry Wrzesinski received $6,650 in industry payments from 2016 to 2025
CMS Open Payments shows 27 general payments to Dr. Wrzesinski from 12 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 78% of the total. Amgen Inc. paid the most, $2,399.
General payments to Dr. Wrzesinski by program year, 2016 to 2025
General payments to Dr. Wrzesinski by kind, 2016 to 2025
- Consulting fees$5,16878%
- Food and beverage$1,25319%
- Education$2303%
Companies that paid Dr. Wrzesinski the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Stephen Henry Wrzesinski graduated from State University of NY Upstate Medical University
Dr. Wrzesinski graduated from State University of NY Upstate Medical University in 2002.
- Medical school
Source: Dmand AI Professional Profile Data
Sources for Dr. Stephen Henry Wrzesinski's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Stephen Henry Wrzesinski
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Stephen Henry Wrzesinski's NPI number?
Dr. Stephen Henry Wrzesinski's NPI number is 1780856971. It was assigned on March 27, 2008, and it is active in the NPI Registry.
What kind of doctor is Dr. Stephen Henry Wrzesinski?
Dr. Stephen Henry Wrzesinski is a medical oncologist in Albany, New York. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Stephen Henry Wrzesinski practice?
Dr. Wrzesinski practices at 400 Patroon Creek Blvd, Albany, NY 12206. Dr. Wrzesinski's primary practice is Akira Medical Imaging + Wellness in Albany, New York. Dmand AI also links Dr. Wrzesinski to 4 hospitals, 1 hospice and 1 medical group.
What is Dr. Stephen Henry Wrzesinski's office phone number?
The practice phone on file for Dr. Wrzesinski is (518) 239-5200.
What is Dr. Stephen Henry Wrzesinski's medical license number?
Dr. Wrzesinski holds New York license 260820.
Which hospitals is Dr. Stephen Henry Wrzesinski affiliated with?
Dr. Wrzesinski is affiliated with Albany Medical Center. Dmand AI links Dr. Wrzesinski to 4 more hospitals.
What medical group is Dr. Stephen Henry Wrzesinski part of?
Dr. Wrzesinski is linked to Samaritan Hospital. Dmand AI links Dr. Wrzesinski to 1 more medical group.
Does Dr. Stephen Henry Wrzesinski accept Medicare?
Yes. CMS data shows Dr. Wrzesinski billed Medicare for 34,684 services in 2024, and Dr. Wrzesinski accepts Medicare assignment.
Does Dr. Stephen Henry Wrzesinski offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Wrzesinski as offering telehealth services.
How many Medicare patients does Dr. Stephen Henry Wrzesinski see?
CMS counts 411 Medicare patients who saw Dr. Wrzesinski in 2024, with an average age of 74.
Show 7 more questionsShow fewer questions
What services does Dr. Stephen Henry Wrzesinski bill to Medicare?
In 2024, Dr. Wrzesinski's most billed Medicare services were injected or infused drug (J9271), injected or infused drug (J1453) and injected or infused drug (J0897).
Where did Dr. Stephen Henry Wrzesinski go to medical school?
Dr. Wrzesinski graduated from State University of NY Upstate Medical University in 2002.
What drugs does Dr. Stephen Henry Wrzesinski prescribe most?
In 2024 Medicare Part D data, Dr. Wrzesinski's most prescribed drugs by claims were Dexamethasone, Eliquis and Levothyroxine Sodium.
Has Dr. Stephen Henry Wrzesinski received payments from drug or device companies?
CMS Open Payments shows $6,650 in general payments to Dr. Wrzesinski from 12 companies from 2016 to 2025. The largest total came from Amgen Inc.
How long has Dr. Stephen Henry Wrzesinski been practicing?
Dr. Wrzesinski graduated from medical school in 2002, 24 years ago.
Does Dr. Stephen Henry Wrzesinski do research?
Dmand AI links 9 publications to Dr. Wrzesinski, published from 2010 to 2022. Dr. Wrzesinski has worked on 2 clinical trials.
Who does Dr. Stephen Henry Wrzesinski publish with?
Dr. Wrzesinski's most frequent co-authors are Atu Agawu, MD, MPH (1 shared paper), Zainub Ajmal, MD (1 shared paper) and Marc Stuart Ernstoff, MD (1 shared paper).
Selling to medical oncology practices?
See medical oncologists in New York by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card